InterIM Note AGREEMENTInterim Note Agreement • July 8th, 2016 • Rock Creek Pharmaceuticals, Inc. • Medicinal chemicals & botanical products
This Interim Note Agreement (the “Agreement”) dated as of July 7, 2016, is by and among Rock Creek Pharmaceuticals, Inc., a Delaware corporation with offices located at 2040 Whitfield Avenue, Suite 300, Sarasota, Florida 34243 (the “Company”), and the investor signatory hereto (the “Investor”).
